Evidence map›Paper›PMID 29599245›Full record

ArticleScience (New York, N.Y.)2018

Binding of ISRIB reveals a regulatory site in the nucleotide exchange factor eIF2B.

Alisa F Zyryanova, Félix Weis, Alexandre Faille, Akeel Abo Alard, Ana Crespillo-Casado, Yusuke Sekine, Heather P Harding, Felicity Allen, Leopold Parts, Christophe Fromont and 3 more

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 134 papers.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 226 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Function and regulation of the mitochondrial stress response.Nature structural & molecular biology · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. The strategies and advances of mRNA translation booster.Asian journal of pharmaceutical sciences · 2025
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Alisa F ZyryanovaCambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK. az310@cam.ac.uk ajw1000@cam.ac.uk dr360@medschl.cam.ac.uk.ORCID 0000-0002-9885-6012
Félix WeisCambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK.ORCID 0000-0002-8137-3532
Alexandre FailleCambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK.
Akeel Abo AlardDivision of Biomolecular Science and Medicinal Chemistry, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK.ORCID 0000-0002-6141-6320
Ana Crespillo-CasadoCambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK.ORCID 0000-0002-7230-3188
Yusuke SekineCambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK.
Heather P HardingCambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK.ORCID 0000-0002-7359-7974
Felicity AllenWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.ORCID 0000-0002-8694-3936
Leopold PartsWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
Christophe FromontDivision of Biomolecular Science and Medicinal Chemistry, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK.ORCID 0000-0002-7295-6023
Peter M FischerDivision of Biomolecular Science and Medicinal Chemistry, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK.ORCID 0000-0002-5866-9271
Alan J WarrenCambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK. az310@cam.ac.uk ajw1000@cam.ac.uk dr360@medschl.cam.ac.uk.ORCID 0000-0001-9277-4553
David RonCambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK. az310@cam.ac.uk ajw1000@cam.ac.uk dr360@medschl.cam.ac.uk.ORCID 0000-0002-3014-5636
University of Cambridge · GBUniversity of Nottingham · GBMRC Laboratory of Molecular Biology · GBWellcome Sanger Institute · GBWellcome/MRC Cambridge Stem Cell Institute · GB

Funding

Medical Research Council MC_U105161083Medical Research Council MR/L003368/1Wellcome Trust 200848/Z/16/Z
6 · The paper itself

Abstract

The integrated stress response (ISR) is a conserved translational and transcriptional program affecting metabolism, memory, and immunity. The ISR is mediated by stress-induced phosphorylation of eukaryotic translation initiation factor 2α (eIF2α) that attenuates the guanine nucleotide exchange factor eIF2B. A chemical inhibitor of the ISR, ISRIB, reverses the attenuation of eIF2B by phosphorylated eIF2α, protecting mice from neurodegeneration and traumatic brain injury. We describe a 4.1-angstrom-resolution cryo-electron microscopy structure of human eIF2B with an ISRIB molecule bound at the interface between the β and δ regulatory subunits. Mutagenesis of residues lining this pocket altered the hierarchical cellular response to ISRIB analogs in vivo and ISRIB binding in vitro. Our findings point to a site in eIF2B that can be exploited by ISRIB to regulate translation.

Indexed as

AcetamidesAnimalsCryoelectron MicroscopyCyclohexylaminesEukaryotic Initiation Factor-2BHeLa CellsHumansMiceMutagenesisPhosphorylationProtein BindingProtein BiosynthesisProtein ConformationStress, Physiological2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido)cyclohexyl)acetamideAcetamidesCyclohexylaminesEukaryotic Initiation Factor-2B

Identifiers

PMID29599245
PMCPMC5889100
OpenAlexW2794506661

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.